Redsense Medical AB (publ) (XSAT:REDS)
Sweden · Delayed Price · Currency is SEK 3.200
-0.030 (-0.93%)
At close: Aug 26, 2026
Redsense Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.62 | 7.36 | 15.36 | 6.97 | 3.67 | 4.98 |
Short-Term Investments | - | - | - | - | 6.91 | 21.97 |
Cash & Short-Term Investments | 4.62 | 7.36 | 15.36 | 6.97 | 10.58 | 26.95 |
Cash Growth | -68.59% | -52.10% | 120.44% | -34.16% | -60.74% | -58.55% |
Accounts Receivable | 5.56 | 6.25 | 6.1 | 2.97 | 4.93 | 3.53 |
Other Receivables | 0.22 | 0.39 | 0.2 | 1.76 | 0.33 | 0.67 |
Receivables | 5.78 | 6.63 | 6.3 | 4.72 | 5.26 | 4.2 |
Inventory | 12.05 | 8.7 | 5.99 | 1.36 | 1.53 | 1.38 |
Prepaid Expenses | 0.53 | 0.58 | 0.35 | 0.2 | 0.64 | 0.41 |
Other Current Assets | 0 | 0 | - | - | - | - |
Total Current Assets | 22.97 | 23.28 | 27.99 | 13.24 | 18.01 | 32.94 |
Property, Plant & Equipment | 0.24 | 0.27 | 0.31 | 0.36 | 0.37 | 0.37 |
Long-Term Deferred Charges | 15.42 | 15.72 | 13.5 | 12.91 | 12.35 | 9.94 |
Other Long-Term Assets | - | 0 | - | 0 | -0 | - |
Total Assets | 38.63 | 39.26 | 41.8 | 26.51 | 30.73 | 43.25 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.69 | 1.99 | 0.52 | 1.75 | 0.98 | 1.33 |
Accrued Expenses | 1.21 | 1.11 | 1.23 | 1.36 | 2.14 | 0.84 |
Other Current Liabilities | 0.13 | 1.88 | 0.46 | 0.31 | 0.47 | 1.02 |
Total Current Liabilities | 3.03 | 4.98 | 2.21 | 3.41 | 3.58 | 3.19 |
Long-Term Debt | - | - | - | - | - | 2.57 |
Total Liabilities | 3.03 | 4.98 | 2.21 | 3.41 | 3.58 | 5.76 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.64 | 1.64 | 1.64 | 1.4 | 1.4 | 1.4 |
Additional Paid-In Capital | - | - | - | - | - | 123.63 |
Retained Earnings | 33.96 | 32.64 | 37.94 | 21.69 | 25.75 | -87.54 |
Comprehensive Income & Other | 0 | 0 | 0 | - | - | 0 |
Shareholders' Equity | 35.61 | 34.28 | 39.59 | 23.1 | 27.15 | 37.49 |
Total Liabilities & Equity | 38.63 | 39.26 | 41.8 | 26.51 | 30.73 | 43.25 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | - | 2.57 |
Net Cash (Debt) | 4.62 | 7.36 | 15.36 | 6.97 | 10.58 | 24.38 |
Net Cash Growth | -68.59% | -52.10% | 120.44% | -34.16% | -56.60% | -62.51% |
Net Cash Per Share | 0.25 | 0.41 | 0.90 | 0.49 | 0.75 | 1.74 |
Filing Date Shares Outstanding | 16.44 | 16.44 | 16.44 | 14.04 | 14.04 | 14.04 |
Total Common Shares Outstanding | 16.44 | 16.44 | 16.44 | 14.04 | 14.04 | 14.04 |
Working Capital | 19.94 | 18.3 | 25.78 | 9.83 | 14.43 | 29.75 |
Book Value Per Share | 2.17 | 2.08 | 2.41 | 1.64 | 1.93 | 2.67 |
Tangible Book Value | 35.61 | 34.28 | 39.59 | 23.1 | 27.15 | 37.49 |
Tangible Book Value Per Share | 2.17 | 2.08 | 2.41 | 1.64 | 1.93 | 2.67 |
Machinery | - | 0.56 | 0.55 | 0.53 | 0.48 | 0.43 |